BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6981802)

  • 1. Evaluation of assays to detect immune complexes as an immunodiagnostic aid in patients with melanoma.
    Ruell P; Murray E; McCarthy WH; Hersey P
    Oncodev Biol Med; 1982; 3(1):1-12. PubMed ID: 6981802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
    Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
    Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM; Moore M; Hilton AM
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating immune complexes in patients with squamous cell carcinoma of the oral cavity.
    Mukhopadhyaya R; Rao RS; Fakih AR; Gangal SG
    J Clin Lab Immunol; 1986 Dec; 21(4):189-93. PubMed ID: 3494132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is the demonstration of immune complex useful in the activity assessment of chronic polyarthritis?].
    Schlumpf U; Ernst R; Christen P; von Felten A; Böni A
    Schweiz Med Wochenschr; 1984 Jan; 114(4):118-30. PubMed ID: 6367028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes detected by C1q solid phase assay in leprosy.
    Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of immune complexes in human cancer sera.
    Theofilopoulos AN; Andrews BS; Urist MM; Morton DL; Dixon FJ
    J Immunol; 1977 Aug; 119(2):657-63. PubMed ID: 886189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephelometric detection of circulating immune complexes using monoclonal rheumatoid factor.
    Whitsed H; McCarthy WH; Hersey P
    J Immunol Methods; 1979; 29(4):311-21. PubMed ID: 390048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
    Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
    Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in end-stage renal disease: comparative and kinetic studies of various types of complexes.
    Favre H; Glasson P; Perez GO; Lambert PH; Leski M
    Adv Nephrol Necker Hosp; 1983; 12():205-13. PubMed ID: 6404136
    [No Abstract]   [Full Text] [Related]  

  • 15. [Circulating immune complexes in a population of subjects seropositive for rheumatoid factor].
    Aureli G; Battista V; Bianchi L; Bolzonetti A; Cipriani A; Carnevali GF; Caschera F; Caputo B; Danieli G; Corvetta A
    Boll Ist Sieroter Milan; 1982; 61(5):367-74. PubMed ID: 6985415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
    Poulton TA; Mooney NA; Nineham LJ; Hay FC
    Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of circulating immune complexes in normal subjects using four different methods.
    Di Mario U; Guy K; Irvine WJ
    J Clin Lab Immunol; 1981 Mar; 5(2):95-9. PubMed ID: 6971334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in Behçet's disease.
    Inoue T; Oniki S; Kajiyama K; Jimi S
    Jpn J Ophthalmol; 1983; 27(1):35-9. PubMed ID: 6602236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
    Shepherd PS
    Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro methods for detection of circulating immune complexes.
    Blackstock R
    Ann Clin Lab Sci; 1981; 11(3):262-8. PubMed ID: 7018370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.